JP2014240389A5 - - Google Patents

Download PDF

Info

Publication number
JP2014240389A5
JP2014240389A5 JP2014130313A JP2014130313A JP2014240389A5 JP 2014240389 A5 JP2014240389 A5 JP 2014240389A5 JP 2014130313 A JP2014130313 A JP 2014130313A JP 2014130313 A JP2014130313 A JP 2014130313A JP 2014240389 A5 JP2014240389 A5 JP 2014240389A5
Authority
JP
Japan
Prior art keywords
seq
group
skin
cosmetic composition
kallikrein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014130313A
Other languages
English (en)
Japanese (ja)
Other versions
JP5891266B2 (ja
JP2014240389A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014240389A publication Critical patent/JP2014240389A/ja
Publication of JP2014240389A5 publication Critical patent/JP2014240389A5/ja
Application granted granted Critical
Publication of JP5891266B2 publication Critical patent/JP5891266B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014130313A 2008-01-21 2014-06-25 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用 Expired - Fee Related JP5891266B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2238608P 2008-01-21 2008-01-21
US61/022,386 2008-01-21
US657608P 2008-01-22 2008-01-22
US61/006,576 2008-01-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010542703A Division JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Publications (3)

Publication Number Publication Date
JP2014240389A JP2014240389A (ja) 2014-12-25
JP2014240389A5 true JP2014240389A5 (cg-RX-API-DMAC7.html) 2015-02-12
JP5891266B2 JP5891266B2 (ja) 2016-03-22

Family

ID=40901490

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010542703A Expired - Fee Related JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用
JP2014130313A Expired - Fee Related JP5891266B2 (ja) 2008-01-21 2014-06-25 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010542703A Expired - Fee Related JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Country Status (8)

Country Link
US (3) US20110130338A1 (cg-RX-API-DMAC7.html)
EP (1) EP2244728B1 (cg-RX-API-DMAC7.html)
JP (2) JP5615184B2 (cg-RX-API-DMAC7.html)
CN (2) CN110522905A (cg-RX-API-DMAC7.html)
AU (1) AU2009207394B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0906167A2 (cg-RX-API-DMAC7.html)
CA (1) CA2712512C (cg-RX-API-DMAC7.html)
WO (1) WO2009093119A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009207394B2 (en) 2008-01-21 2015-01-22 Dermadis Sa Use of serine protease inhibitors in the treatment of skin diseases
CN102448473A (zh) * 2009-03-10 2012-05-09 Med发现公司 丝氨酸蛋白酶抑制剂在治疗嗜中性粒细胞减少症中的用途
EP2799471B1 (en) 2011-12-09 2019-04-24 Momentive Performance Materials Japan LLC Method for producing silicone rubber foam
CA2881431C (en) * 2012-08-08 2021-10-19 Daiichi Sankyo Company, Limited Peptide library and use thereof
KR101830926B1 (ko) * 2012-09-19 2018-02-22 맥케이 메모리얼 호스피탈 피부 노화를 방지 및/또는 개선하기 위해 사용되는 pedf-유도 폴리펩티드의 용도
KR101437408B1 (ko) 2012-11-05 2014-09-05 동아대학교 산학협력단 플라스민 및 엘라스타아제 저해 활성을 갖는 산왕거미 유래의 쿠니츠 타입 세린 프로테아제 저해 단백질 및 이를 유효성분으로 포함하는 염증 억제 및 항섬유소용해용 조성물
US10807805B2 (en) 2013-05-17 2020-10-20 Intelligrated Headquarters, Llc Robotic carton unloader
US9969573B2 (en) 2013-05-17 2018-05-15 Intelligrated Headquarters, Llc Robotic carton unloader
GB201322091D0 (en) * 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
WO2015114144A1 (en) * 2014-02-03 2015-08-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of netherton syndrome
AU2015223035A1 (en) * 2014-02-26 2016-09-22 Luma Therapeutics, Inc. Ultraviolet phototherapy apparatuses and methods
WO2016063991A1 (ja) * 2014-10-24 2016-04-28 株式会社資生堂 角層剥離の抑制又は亢進に起因する肌状態を改善するための美容方法及び評価方法
MA40998A (fr) 2014-11-21 2017-09-26 Ophirex Inc Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés
US10597235B2 (en) 2016-10-20 2020-03-24 Intelligrated Headquarters, Llc Carton unloader tool for jam recovery
CN106478812B (zh) * 2016-10-21 2020-11-20 沈阳药科大学 丝氨酸蛋白酶抑制剂-3及其功能、制备方法和应用
TW202313978A (zh) * 2016-11-23 2023-04-01 美商阿尼拉製藥公司 絲胺酸蛋白酶抑制因子A1 iRNA組成物及其使用方法
TW201841656A (zh) * 2017-04-21 2018-12-01 美商建南德克公司 Klk5拮抗劑用於治療疾病之用途
EP4740954A3 (en) * 2017-06-16 2026-08-05 Azitra, Inc. Compositions and methods for treatment of netherton syndrome with lekti expressing recombinant microbes
US20200040103A1 (en) 2018-03-14 2020-02-06 Genentech, Inc. Anti-klk5 antibodies and methods of use
AU2019346549B2 (en) 2018-09-24 2024-09-12 Krystal Biotech, Inc. Compositions and methods for the treatment of Netherton Syndrome
AU2020349509A1 (en) 2019-09-18 2022-03-31 Genentech, Inc. Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use
JP7768560B2 (ja) * 2019-11-21 2025-11-12 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 好中球エラスターゼ活性のポリペプチド阻害剤およびその使用
GB202001447D0 (en) 2020-02-03 2020-03-18 Ucb Biopharma Sprl Antibodies
EP4114414A4 (en) * 2020-03-06 2024-03-27 The Regents of The University of Michigan SERINE PROTEASE INHIBITORS FOR SUPPRESSING OR PREVENTING ANAPHYLACTIC REACTION
CN112315897A (zh) * 2020-11-04 2021-02-05 深圳前海鹰岗生物科技有限公司 一种抑制细胞炎症反应释放治疗痛风急性发作的聚合物微针及制备方法
JP2025502341A (ja) * 2022-01-18 2025-01-24 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 加齢における分解性プロテアーゼ活性を阻害する方法
JP7820193B2 (ja) * 2022-03-04 2026-02-25 株式会社ナリス化粧品 角層剥離改善剤
AU2024212280A1 (en) * 2023-01-25 2025-05-22 Quoin Pharmaceuticals, Inc. Combination treatment for netherton syndrome
CN117084936A (zh) * 2023-09-22 2023-11-21 南京盛德生物科技研究院有限公司 多萜类化合物作为激肽释放酶抑制剂在化妆品中的应用
WO2026021603A1 (zh) * 2024-07-25 2026-01-29 吉林大学第一医院 Serpina3蛋白变异体或其编码序列以及它们的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
ATE278417T1 (de) * 1999-06-18 2004-10-15 Jon Bragi Bjarnason Pharmazeutische- und kosmetischezusammensetzungen enthaldend serinproteasen aus kabeljau und deren pharmazeutische und kosmetische verwendung
US7105172B1 (en) * 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
EP1334179A2 (en) * 2000-11-14 2003-08-13 Bristol-Myers Squibb Company A human serpin secreted from lymphoid cells lsi-01
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
AU2003286258B2 (en) * 2002-11-20 2006-12-21 Arriva-Prometic Inc. Composition and method for treating inflammatory diseases using protease inhibitors
US8975370B2 (en) * 2003-04-04 2015-03-10 Universite De Lausanne Inhibitor proteins of a protease and use thereof
WO2005117955A1 (en) * 2004-05-19 2005-12-15 Arriva Pharmaceuticals, Inc. Treatment of atopic dermatitis with unglycosylated alpha one-antitrypsin
EP1666075A1 (en) * 2004-10-04 2006-06-07 Switch Biotech Aktiengesellschaft Wound dressing compositions, especially for delivery of protease inhibitors
WO2006090282A2 (en) * 2005-02-28 2006-08-31 Universite De Lausanne Recombinant inhibitor proteins of an hk14 protease and use thereof
GB0525999D0 (en) * 2005-12-21 2006-02-01 Ares Trading Sa Novel members of the kazal family of serine protease inhibitors
BRPI0813230A2 (pt) * 2007-06-28 2014-12-23 Novartis Ag Moduladores de calicreína 7
WO2009024528A1 (en) * 2007-08-17 2009-02-26 Novartis Ag Use of cyclic depsipeptides to inhibit kallikrein 7
AU2009207394B2 (en) * 2008-01-21 2015-01-22 Dermadis Sa Use of serine protease inhibitors in the treatment of skin diseases

Similar Documents

Publication Publication Date Title
Levin et al. Next generation matrix metalloproteinase inhibitors—Novel strategies bring new prospects
Siklos et al. Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors
Heutinck et al. Serine proteases of the human immune system in health and disease
Betrosian et al. Purpura fulminans in sepsis
WO2011150284A3 (en) Removal of serine proteases by treatment with finely divided silicon dioxide
EP3623470A3 (en) Factor ix variants with clotting activity in absence of their cofactor and their use for treating bleeding disorders
JP2019077731A5 (cg-RX-API-DMAC7.html)
EA201691558A1 (ru) Удаление сериновых протеаз путем обработки тонкоизмельченным диоксидом кремния
ECSP045115A (es) INDOL-2-CARBOXAMIDAS COMO INHIBIDORES DEL FACTOR Xa
MX2017003624A (es) Compuestos de piridona sustituida con pirazolilo como inhibidores de serina proteasas.
JP2017518370A5 (cg-RX-API-DMAC7.html)
TW200724157A (en) A non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
WO2013061083A3 (en) Therapeutic agents and uses thereof
WO2009093119A3 (en) Use of serine protease inhibitors in the treatment of skin diseases
MY183252A (en) Kallirein 7 modulators
WO2008156817A8 (en) Renin inhibitors
TN2009000503A1 (en) Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
CY1107342T1 (el) Χρηση παραγωγων νιτριλιου ως φαρμακο
WO2009136997A3 (en) Inhibitors of human cathepsin l, cathepsin b, and cathepsin s
MY157366A (en) Therapies and compositions comprising cathepsin s antibodies
WO2007117559A8 (en) Renin inhibitors
WO2007099348A3 (en) Cathepsin propeptide and uses thereof
WO2020023094A3 (en) Treatment of lysosomal storage disorders
ZA200908583B (en) Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation
WO2004012732A3 (en) Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy